Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database

Abstract: The U.S. Food and Drug Administration (FDA) has stated that the prescription of remdesivir should be cautious for patients with estimated glomerular filtration rate (eGFR) < 30 and some studies reported risk of adverse renal events. The available information on the renal safety profile for...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Nayara Aparecida de Oliveira Silva, Ana Laura de Sene Amâncio Zara, Albert Figueras, Daniela Oliveira de Melo
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz 2021-11-01
श्रृंखला:	Cadernos de Saúde Pública
विषय:	Coronavirus Infections Pharmacovigilance Adverse Drug Reaction Reporting Systems Drug-Related Side Effects and Adverse Reactions
ऑनलाइन पहुंच:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2021001005024&tlng=en
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!